Pathnostics
Pre-clinicalOur Flagship Platform: Guidance® - for the rapid identification and precise treatment of complicated, recurrent and persistent UTIs.
Founded
2016
Focus
Diagnostics
About
Our Flagship Platform: Guidance® - for the rapid identification and precise treatment of complicated, recurrent and persistent UTIs.
Funding History
2Total raised: $40M
Series B$25MUndisclosedJun 15, 2021
Series A$15MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2016
LocationIrvine, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile